Literature DB >> 7901777

Chloroethylclonidine irreversibly activates postjunctional alpha 2-adrenoceptors in the dog saphenous vein.

J P Nunes1, S Guimarães.   

Abstract

This study was aimed at analysing the contractile response of the dog saphenous vein to chloroethylclonidine. At 37 degrees C, chloroethylclonidine (0.1-100 mumol.l-1) caused a long-lasting contraction in both proximal and distal segments of the dog saphenous vein, reaching 77.6 and 52.6% of the maximal response to phenylephrine, respectively. At 18 degrees C, and in both segments, the maximal response to chloroethylclonidine was markedly reduced, whereas that to phenylephrine was not changed and that to UK-14,304 was enhanced. The response to chloroethylclonidine was unaffected by pretreatment with cocaine. Warming to 37 degrees C caused contraction of strips which at 18 degrees C had remained unresponsive to chloroethylclonidine, even if these strips were repeatedly washed before warming. At 18 degrees C, chloroethylclonidine (100 mumol.l-1) did not alter the responses to UK-14,304 and phenylephrine. At 37 degrees C, the contractile response to chloroethylclonidine was antagonized by yohimbine, rauwolscine and prazosin, with the potency rank yohimbine = rauwolscine > prazosin. Phenoxybenzamine (30 nmol.l-1) displaced the concentration-response curve to chloroethylclonidine to the right and depressed its maximum. After phenoxybenzamine, yohimbine continued to be more effective than prazosin, which remained very potent.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7901777     DOI: 10.1007/bf00169154

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  23 in total

1.  Adrenergic receptors in the veins of the dog.

Authors:  S Guimarães; W Osswald
Journal:  Eur J Pharmacol       Date:  1969-01       Impact factor: 4.432

2.  Comparison of some properties of pronethalol and propranolol.

Authors:  J W Black; W A Duncan; R G Shanks
Journal:  Br J Pharmacol Chemother       Date:  1965-12

3.  Alpha 2-adrenoceptor-mediated responses to so-called selective alpha 1-adrenoceptor agonists after partial blockade of alpha 1-adrenoceptors.

Authors:  S Guimarães; M Q Paiva; D Moura
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-04       Impact factor: 3.000

Review 4.  Alpha 1-adrenergic receptor subtypes, inositol phosphates, and sources of cell Ca2+.

Authors:  K P Minneman
Journal:  Pharmacol Rev       Date:  1988-06       Impact factor: 25.468

5.  Cooling and alpha 1- and alpha 2-adrenergic responses in cutaneous veins: role of receptor reserve.

Authors:  N A Flavahan; L E Lindblad; T J Verbeuren; J T Shepherd; P M Vanhoutte
Journal:  Am J Physiol       Date:  1985-11

Review 6.  Alpha-adrenoceptor subclassification.

Authors:  K Starke
Journal:  Rev Physiol Biochem Pharmacol       Date:  1981       Impact factor: 5.545

7.  Mechanisms of supersensitivity and subsensitivity to sympathomimetic amines.

Authors:  U Trendelenburg
Journal:  Pharmacol Rev       Date:  1966-03       Impact factor: 25.468

8.  Hypothermia induces supersensitivity of mouse vas deferens to adrenergic agonists: evidence for postjunctional alpha 2-adrenoceptors.

Authors:  J Goncalves; J Proenca; A A Albuquerque; M Q Paiva
Journal:  J Pharm Pharmacol       Date:  1989-01       Impact factor: 3.765

9.  Studies on the potentiation of the inotropic actions of certain catecholamines by U-0521 (3',4'-dihydroxy-alpha-methyl propiophenone).

Authors:  R E Giles; J W Miller
Journal:  J Pharmacol Exp Ther       Date:  1967-07       Impact factor: 4.030

10.  Chloroethylclonidine unmasks a non-alpha-adrenoceptor noradrenaline binding site in the rat aorta.

Authors:  M A Oriowo; J A Bevan
Journal:  Eur J Pharmacol       Date:  1990-03-20       Impact factor: 4.432

View more
  8 in total

1.  Differential response to chloroethylclonidine in blood vessels of normotensive and spontaneously hypertensive rats: role of alpha 1D- and alpha 1A-adrenoceptors in contraction.

Authors:  M Ibarra; J P Pardo; J J Lopez-Guerrero; R Villalobos-Molina
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

2.  The contribution of α1B-adrenoceptor subtype in the renal vasculature of fructose-fed Sprague-Dawley rats.

Authors:  Mohammed H Abdulla; Munavvar A Sattar; Nor A Abdullah; Md Abdul Hye Khan; Kolla R L Anand Swarup; Edward J Johns
Journal:  Eur J Nutr       Date:  2010-09-30       Impact factor: 5.614

3.  Modulation of contraction by alpha(2A/D)-adrenoceptors in mouse aorta: evidence employing knockout technology.

Authors:  Catherine Vandeputte; James R Docherty
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

Review 4.  Classification of alpha 1-adrenoceptor subtypes.

Authors:  M C Michel; B Kenny; D A Schwinn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-07       Impact factor: 3.000

5.  Investigation of the actions of chloroethylclonidine in rat aorta.

Authors:  M O'Rourke; S Kearns; J R Docherty
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

6.  Interactions of chloroethylclonidine with rauwolscine- and prazosin-sensitive adrenoceptors in dog saphenous vein.

Authors:  A M Low; D M Bowdish; T R Prashad; V Gaspar
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

7.  Interaction between nitric oxide and renal α1-adrenoreceptors mediated vasoconstriction in rats with left ventricular hypertrophyin Wistar Kyoto rats.

Authors:  Ashfaq Ahmad; Munavvar A Sattar; Maleeha Azam; Safia A Khan; Owais Bhatt; Edward J Johns
Journal:  PLoS One       Date:  2018-02-15       Impact factor: 3.240

8.  Cystathione gamma lyase/Hydrogen Sulphide Pathway Up Regulation Enhances the Responsiveness of α1A and α1B-Adrenoreceptors in the Kidney of Rats with Left Ventricular Hypertrophy.

Authors:  Ashfaq Ahmad; Munavvar A Sattar; Maleeha Azam; Mohammed H Abdulla; Safia A Khan; Fayyaz Hashmi; Nor A Abdullah; Edward J Johns
Journal:  PLoS One       Date:  2016-05-18       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.